Anna Kostecka

495 total citations
9 papers, 339 citations indexed

About

Anna Kostecka is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Anna Kostecka has authored 9 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Anna Kostecka's work include Bioactive Compounds and Antitumor Agents (2 papers), Single-cell and spatial transcriptomics (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Anna Kostecka is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Single-cell and spatial transcriptomics (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Anna Kostecka collaborates with scholars based in Poland, Sweden and United States. Anna Kostecka's co-authors include Alicja Sznarkowska, Krzysztof Piotr Bielawski, Anna Kawiak, Joanna Zawacka‐Pankau, Elisabeth Hedström, Pilar Acedo, Alberto Inga, Magdalena Koczkowska, Yao Shi and Margareta Wilhelm and has published in prestigious journals such as Life Sciences, Cell Death and Disease and Oncotarget.

In The Last Decade

Anna Kostecka

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kostecka Poland 7 189 94 39 38 28 9 339
Alejandra Gomez‐Cadena Switzerland 16 186 1.0× 83 0.9× 45 1.2× 38 1.0× 18 0.6× 19 643
Andrea Čumová Czechia 7 205 1.1× 88 0.9× 28 0.7× 60 1.6× 24 0.9× 10 406
Rita Tohmé United States 9 290 1.5× 60 0.6× 62 1.6× 49 1.3× 25 0.9× 12 489
Hina Amin India 14 253 1.3× 93 1.0× 54 1.4× 52 1.4× 12 0.4× 19 438
Jin-Jin Lin Taiwan 7 288 1.5× 93 1.0× 44 1.1× 51 1.3× 18 0.6× 9 552
Lirui Sun China 12 163 0.9× 58 0.6× 30 0.8× 74 1.9× 12 0.4× 20 396
Vinod Balachandran India 12 315 1.7× 130 1.4× 48 1.2× 62 1.6× 26 0.9× 14 598
Jun‐Ping Shiau Taiwan 11 252 1.3× 78 0.8× 28 0.7× 79 2.1× 22 0.8× 44 463
Vino T. Cheriyan United States 13 277 1.5× 106 1.1× 53 1.4× 71 1.9× 22 0.8× 22 492
Mohammad Akbar Hossain South Korea 10 192 1.0× 71 0.8× 22 0.6× 66 1.7× 16 0.6× 12 417

Countries citing papers authored by Anna Kostecka

Since Specialization
Citations

This map shows the geographic impact of Anna Kostecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kostecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kostecka more than expected).

Fields of papers citing papers by Anna Kostecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kostecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kostecka. The network helps show where Anna Kostecka may publish in the future.

Co-authorship network of co-authors of Anna Kostecka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kostecka. A scholar is included among the top collaborators of Anna Kostecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kostecka. Anna Kostecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Koczkowska, Magdalena, Anna Kostecka, Kamil Myszczyński, et al.. (2025). Identifying differentiation markers between dermal fibroblasts and adipose-derived mesenchymal stromal cells (AD-MSCs) in human visceral and subcutaneous tissues using single-cell transcriptomics. Stem Cell Research & Therapy. 16(1). 64–64. 5 indexed citations
2.
Kostecka, Anna, et al.. (2024). Adipose-derived mesenchymal stromal cells in clinical trials: Insights from single-cell studies. Life Sciences. 351. 122761–122761. 12 indexed citations
3.
Chojnowska, Katarzyna, Michał Bieńkowski, Anna Kostecka, et al.. (2023). Size matters: the impact of nucleus size on results from spatial transcriptomics. Journal of Translational Medicine. 21(1). 270–270. 6 indexed citations
4.
Kawiak, Anna & Anna Kostecka. (2022). Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy. Cancers. 14(2). 279–279. 42 indexed citations
5.
Sznarkowska, Alicja, Anna Kostecka, Anna Kawiak, et al.. (2018). Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells. Cell Division. 13(1). 10–10. 12 indexed citations
6.
Sznarkowska, Alicja, et al.. (2016). Inhibition of cancer antioxidant defense by natural compounds. Oncotarget. 8(9). 15996–16016. 171 indexed citations
7.
Kostecka, Anna, Alicja Sznarkowska, Pilar Acedo, et al.. (2014). JNK–NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. Cell Death and Disease. 5(10). e1484–e1484. 29 indexed citations
8.
Zawacka‐Pankau, Joanna, Anna Kostecka, Alicja Sznarkowska, Elisabeth Hedström, & Anna Kawiak. (2010). p73 tumor suppressor protein: A close relative of p53 not only in structure but also in anti-cancer approach?. Cell Cycle. 9(4). 720–728. 56 indexed citations
9.
Milewicz, Tomasz, et al.. (2007). [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].. PubMed. 64(2). 65–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026